Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Skin Neoplasms 1Pancreatic Neoplasms 1

Interventions

Etoposide 17Filgrastim 16Carboplatin 16Ifosfamide 15Peripheral Blood Stem Cell Transplantation 14Cisplatin 14Paclitaxel 12Cyclophosphamide 8Bleomycin 7Radiotherapy 6pegfilgrastim 4Thiotepa 4Flow Cytometry 4etoposide phosphate 3Immunologic Techniques 3sargramostim 2aldesleukin 2Vinblastine 2Temozolomide 2Polymerase Chain Reaction 2Microarray Analysis 2Methylprednisolone 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Granisetron 2Gemcitabine 2Dexamethasone 2Busulfan 2Amplified Fragment Length Polymorphism Analysis 2Alemtuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Germ Cell Tumor × In Situ Hybridization × Genitourinary × Clear all
NCT00899132 2015-09-29

Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Case Comprehensive Cancer Center

Terminated
180 enrolled
DermatologicGastrointestinalGenitourinary

Teratoma, Testicular, Testicular Germ Cell Tumor, Pancreatic Neoplasms, Skin Neoplasms, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡